Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping.

scientific article published on 8 March 2011

Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/TPJ.2011.8
P932PMC publication ID3325368
P698PubMed publication ID21383772
P5875ResearchGate publication ID50304894

P50authorPär MatssonQ37386218
Sook Wah YeeQ80541004
P2093author name stringK M Giacomini
E Jorgenson
G Jenkins
D L Kroetz
J Xuan
S Markova
K Morrissey
P2860cites workGenome-wide associations of gene expression variation in humansQ21145274
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasisQ22004274
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiencyQ22010457
Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart AssociationQ22306345
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transportersQ24290568
ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteinsQ24306627
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA estersQ24308754
Phosphatidylcholine translocase: a physiological role for the mdr2 geneQ24319732
Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorptionQ24539051
Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II regionQ24560017
A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression patternQ24567552
Common genetic variants account for differences in gene expression among ethnic groupsQ24626446
Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait lociQ24631841
Genome-wide identification of DNaseI hypersensitive sites using active chromatin sequence librariesQ24633720
Ultraconservation identifies a small subset of extremely constrained developmental enhancersQ24648269
Altered expression of ALDP in X-linked adrenoleukodystrophyQ24671055
PLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transportQ24678486
A comparison of normalization methods for high density oligonucleotide array data based on variance and biasQ27860710
Haploview: analysis and visualization of LD and haplotype mapsQ27860955
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genomeQ28131828
Scanning Human Gene Deserts for Long-Range EnhancersQ28210571
Genetic structure of human populationsQ28218564
ChIP-seq accurately predicts tissue-specific activity of enhancersQ28235102
High-resolution mapping and characterization of open chromatin across the genomeQ28266995
Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxelQ28272300
The role of ABC transporters in drug resistance, metabolism and toxicityQ28283237
Genomic maps and comparative analysis of histone modifications in human and mouseQ29614418
A genome-wide association study of global gene expressionQ29614592
Population genomics of human gene expressionQ29614905
In vivo enhancer analysis of human conserved non-coding sequencesQ29616554
Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.Q31942201
High-resolution mapping of expression-QTLs yields insight into human gene regulationQ33375030
Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell linesQ34288272
Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout miceQ34913579
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.Q35048738
DNA marker haplotype association with pancreatic sufficiency in cystic fibrosisQ35248559
The MRP family of drug efflux pumpsQ35567296
Gene-expression variation within and among human populationsQ35677775
Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approachQ35946327
Evaluation of genetic variation contributing to differences in gene expression between populationsQ36718956
Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).Q37162177
Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general populationQ37591896
Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancyQ37737633
Comment on "Genetic structure of human populations".Q38996711
ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancerQ39905259
Catalytic site modifications of TAP1 and TAP2 and their functional consequences.Q40215001
Metrics of sequence constraint overlook regulatory sequences in an exhaustive analysis at phox2bQ42239743
Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2).Q43127132
When good drugs go bad.Q45975464
Japan Arteriosclerosis Longitudinal Study-Existing Cohorts Combine (JALS-ECC): rationale, design, and population characteristicsQ46410488
Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels.Q46805420
Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.Q52519846
Qualifying the relationship between sequence conservation and molecular functionQ80620353
The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studiesQ81612489
P433issue3
P921main subjectquantitative traitQ112670498
trait mappingQ117704033
P304page(s)214-226
P577publication date2011-03-08
P1433published inThe Pharmacogenomics JournalQ10534704
P1476titleDiscovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping
P478volume12

Reverse relations

cites work (P2860)
Q34360091ABCD2 alters peroxisome proliferator-activated receptor α signaling in vitro, but does not impair responses to fenofibrate therapy in a mouse model of diet-induced obesity
Q46418563ABCG2 regulatory single-nucleotide polymorphisms alter in vivo enhancer activity and expression
Q38884180Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant
Q89890455Genetic Diversity in Drug Transporters: Impact in African Populations
Q38730592In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus
Q35799841Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation
Q38629883Pharmacogenomics considerations in the control of hypertension
Q27025558Pharmacogenomics of chemotherapeutic susceptibility and toxicity
Q36252524Relating human genetic variation to variation in drug responses
Q96953681Statin Use Associates With Risk of Type 2 Diabetes via Epigenetic Patterns at ABCG1
Q36203536The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era.